Mostrando 7 resultados de: 7
Filtros aplicados
Subtipo de publicación
Article(7)
Publisher
Pharmaceutics(3)
International Journal of Molecular Sciences(1)
Nanomedicine: Nanotechnology, Biology, and Medicine(1)
Pharmaceuticals(1)
Plants(1)
Área temáticas
Farmacología y terapéutica(7)
Enfermedades(3)
Fisiología y materias afines(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Origen
scopus(7)
Characterization and In Vivo Anti-Inflammatory Efficacy of Copal (Dacryodes peruviana (Loes.) H.J. Lam) Essential Oil
ArticleAbstract: Essential oils are natural aromatic substances that contain complex mixtures of many volatile compouPalabras claves:Dacryodes peruviana, Essential oil, inflammation, limonene, Α-phellandreneAutores:Calpena A.C., Eduardo Valarezo, Fábrega M.J., Lupe Carolina Espinoza, Mallandrich M., Rodríguez-Lagunas M.J., Sosa L.Fuentes:scopusApremilast microemulsion as topical therapy for local inflammation: Design, characterization and efficacy evaluation
ArticleAbstract: Apremilast (APR) is a selective phosphodiesterase 4 inhibitor administered orally in the treatment oPalabras claves:Apremilast, inflammation, Microemulsion, Phosphodiesterase 4, Skin DiseasesAutores:Badia J., Calpena A.C., Díaz-Garrido N., Fábrega M.J., Halbaut L., Lupe Carolina Espinoza, Paulo Sarango-Granda, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusEffect of Penetration Enhancers and Safety on the Transdermal Delivery of Apremilast in Skin
ArticleAbstract: The poor water solubility of apremilast (APR) is the main impediment to the penetration of the drugPalabras claves:Apremilast, Promoter, Skin, squaleneAutores:Alvarado H., Baldomá L., Calpena A.C., Díaz-Garrido N., Lupe Carolina Espinoza, Paulo Sarango-Granda, Rodríguez-Lagunas M.J.Fuentes:scopusNanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases
ArticleAbstract: Pioglitazone (PGZ)is a peroxisome proliferator-activated receptor agonist. Its role in the inflammatPalabras claves:anti-inflammatory activity, cytokines, NANOEMULSIÓN, Pioglitazone, Skin disordersAutores:Calpena A.C., Clares-Naveros B., Fábrega M.J., Garduño-Ramírez M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusHuman skin permeation studies with PPARγ agonist to improve its permeability and efficacy in inflammatory processes
ArticleAbstract: Rosacea is the most common inflammatory skin disease. It is characterized by erythema, inflammatoryPalabras claves:inflammation, limonene, Pioglitazone, PPAR-γ, ROSÁCEA, Skin permeationAutores:Calpena A.C., Espina M., Fábrega M.J., García M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusThermoreversible gel-loaded amphotericin B for the treatment of dermal and vaginal candidiasis
ArticleAbstract: The present study was designed to develop a thermoreversible gel of Pluronic (P407) loaded amphoteriPalabras claves:Amphotericin B, Candidiasis, Poloxamer 407, Skin and vaginal mucosa, Thermoreversible gelAutores:Bozal N., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rincón M., Rodríguez-Lagunas M.J., Silva-Abreu M., Sosa L.Fuentes:scopusTopical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model
ArticleAbstract: Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show aPalabras claves:Atopic dermatitis, NANOEMULSIÓN, Pioglitazone, Pluronic F127Autores:Badia J., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M., Vera-García R.Fuentes:scopus